Merging high-potency and green chemistry expertise, Indena and TCG GreenChem are setting new global standards in ...

At EASD 2025, investigators reported one-year outcomes from a study of zimislecel (VX-880), an allogeneic, stem cell-derived ...

Recent headlines from the Financial Times highlight China's testing of new AI chip-making tools, questions in the UK about ...

India is well on its way to become a global leader in medical technology, with a long-term vision to significantly expand its ...

Mankind Pharma collaborates with OpenAI to integrate AI across its value chain for improved efficiency and innovation.

The company has expanded its CDMO offerings in recent years, adding to decades of experiences in solutions such as moisture management.

Marjorie Taylor Greene purchased 12 stocks at the end of August, including Alphabet Class C shares, Merck & Co., Exelon Corp.

Pharma marketers see AI as shifting beyond being just a productivity tool to one that can foster trust among consumers.

That’s according to Will Reese, chief innovation officer at Inizio Evoke, who spoke with Fierce Pharma Marketing during last ...

President Donald Trump’s state visit to the UK has delivered pledges from US tech giants to invest a combined $42 billion to ...

In conversation with Mark Green, founder and CEO of Change Rebellion, pharmaphorum seeks practical advice for our readers who ...

Germany-headquartered technology giant Merck has set its sights on becoming the "best partner of choice" in the ...